Abstract
I thank Tishler and Reiss1 for their thoughtful article in the May 2011 issue of Pediatrics . I agree that further guidance from regulatory authorities (eg, the US Food and Drug Administration or Office for Human Research Protections) would be useful in regards to the issue of incentives for study participation, because there is significant variation from study to study and even among clinical …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
